No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Elixirr International reported a strong performance for the financial year ended 31 December in a trading update on Tuesday, with results set to exceed market expectations.
The AIM-traded firm said revenue was projected to surpass £111m, exceeding the company's guidance range of £108m to £111m.
Adjusted EBITDA was anticipated to be about £31m, with a margin of around 28%, in the middle of the previously indicated range of 27% to 29%.
The consultancy said it had also strengthened its balance sheet, fully repaying debt drawn under its £45m revolving credit facility used to finance the acquisition of Hypothesis Group.
At year-end, cash balances stood at around £7.5m.
The company said it was continuing to meet the 'rule of 40', with the combined sum of revenue growth and adjusted EBITDA margin exceeding 40% every year since its initial public offering.
Momentum had carried into 2025, with January revenue setting a record.
Elixirr said it would release its full-year results for 2024 on 28 April.
At 0939 GMT, shares in Elixirr International were up 8.53% at 840p.
Reporting by Josh White for Sharecast.com.
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.
